Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors

Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with...

Related Keywords

San Diego ,California ,United States ,Eli Lilly ,Carmine Stengone ,Troy Ignelzi ,Johnson ,Rapport Therapeutics Inc ,Nasdaq ,Cincor Pharma Inc ,Audit Committee ,Bristol Myers Squibb ,Astrazeneca ,Insys Therapeutics Inc ,Karuna Therapeutics Inc ,Ferris State University ,Esperion Therapeutics Inc ,Contineum Therapeutics Inc ,Contineum Therapeutics ,Chief Executive Officer ,Chief Financial Officer ,Rapport Therapeutics ,Karuna Therapeutics ,Juventas Therapeutics ,Esperion Therapeutics ,Insys Therapeutics ,Cincor Pharma ,Vedanta Biosciences ,Executive Advisor ,Johnson Innovative ,Financial Condition ,